News aus dem Fachbereich

The co-expression of CD26 and TGF-β1 renders lung cancer targetable to CD26-inhibition

Congratulations to Wolfgang Jungraithmayr for receiving the price "B. Braun Award to N. Enz and W. Jungraithmayr, 54th annual meeting of the ESSR"​ for his work on The co-expression of CD26 and TGF-β1 renders lung cancer targetable to CD26-inhibition.

Wolfgang Jungraithmayr, Prof. Dr. Dr. med.

Forschungsgruppenleiter, Klinik für Thoraxchirurgie

Verantwortlicher Fachbereich